Healthcare -
Biotechnology - NASDAQ - US
$ 1.81
2.84 %
$ 1.15 B
Market Cap
-6.7
P/E
GERN - CASH FROM OPERATIONS
Cash from Operations GERN - Geron Corporation
-168 M
LAST VALUE
-32.49%
2 YEAR CAGR
-51.51%
5 YEAR CAGR
-16.42%
10 YEAR CAGR